Quantitative imaging in cardiac transthyretin amyloidosis: rationale and design of the i-CARE study.

Saved in:
Bibliographic Details
Title: Quantitative imaging in cardiac transthyretin amyloidosis: rationale and design of the i-CARE study.
Authors: Tingen HSA; Department of Nuclear Medicine and Molecular Imaging, Groningen Amyloidosis Center of Expertise, Groningen University, University Medical Centre Groningen, Netherlands. h.s.a.tingen@umcg.nl., Balmforth C; BHF Centre for Cardiovascular Science, University of Edinburgh, United Kingdom., Craig N; BHF Centre for Cardiovascular Science, University of Edinburgh, United Kingdom., Tubben A; Department of Cardiology, Groningen Amyloidosis Center of Expertise, Groningen University, University Medical Centre Groningen, Netherlands., Dobrolinska MM; Department of Nuclear Medicine and Molecular Imaging, Groningen Amyloidosis Center of Expertise, Groningen University, University Medical Centre Groningen, Netherlands., Joshi SS; BHF Centre for Cardiovascular Science, University of Edinburgh, United Kingdom., Fontana M; National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom., Aus dem Siepen F; Department of Cardiology, University of Heidelberg, Germany., Newby DE; BHF Centre for Cardiovascular Science, University of Edinburgh, United Kingdom.; Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, United Kingdom., Nienhuis HLA; Department of Internal Medicine, Groningen Amyloidosis Center of Expertise, Groningen University, University Medical Centre Groningen, Netherlands., van der Meer P; Department of Cardiology, Groningen Amyloidosis Center of Expertise, Groningen University, University Medical Centre Groningen, Netherlands., Hegenbart U; Department of Hematology and Oncology, Amyloidosis Center, University of Heidelberg, Germany., Wagner T; Department of Nuclear Medicine, Royal Free London NHS Trust, London, United Kingdom.; Centre for Medical Imaging, Division of Medicine, University College London, United Kingdom., Venneri L; National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom., Visgnanamoorthy V; National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom., Dweck MR; BHF Centre for Cardiovascular Science, University of Edinburgh, United Kingdom.; Edinburgh Imaging, Queen's Medical Research Institute, Edinburgh, United Kingdom., Slart RHJA; Department of Nuclear Medicine and Molecular Imaging, Groningen Amyloidosis Center of Expertise, Groningen University, University Medical Centre Groningen, Netherlands.; Biomedical Photonic Imaging Group, Faculty of Science and Technology, University of Twente, Enschede, Netherlands.
Source: Cardiology journal [Cardiol J] 2026; Vol. 33, pp. e00226046.
Publication Type: Journal Article
Journal Info: Publisher: Via Medica Country of Publication: Poland NLM ID: 101392712 Publication Model: Print Cited Medium: Internet ISSN: 1898-018X (Electronic) Linking ISSN: 1898018X NLM ISO Abbreviation: Cardiol J Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1898-018X
DOI:10.5603/cj.106172